159 related articles for article (PubMed ID: 35123118)
1. Impact of Human T Cell Lymphotropic Virus Type 1 and 2 Infection on Survival Following Stem Cell Transplantation.
Gupta VK; El-Jawahri A; Orkev G; Johnson MH; Weinberg J; Goodrich C; Janakiram M; Sloan JM
Transplant Cell Ther; 2022 May; 28(5):276.e1-276.e5. PubMed ID: 35123118
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Allogeneic Hematopoietic Cell Transplantation in Human T Cell Lymphotropic Virus Type 1-Associated Adult T Cell Leukemia/Lymphoma: Results of a Systematic Review/Meta-Analysis.
Iqbal M; Reljic T; Klocksieben F; Sher T; Ayala E; Murthy H; Bazarbachi A; Kumar A; Kharfan-Dabaja MA
Biol Blood Marrow Transplant; 2019 Aug; 25(8):1695-1700. PubMed ID: 31132453
[TBL] [Abstract][Full Text] [Related]
3. The clinical impact of human T-lymphotrophic virus type 1 (HTLV-1) infection on the development of adult T-cell leukemia-lymphoma (ATL) or HTLV-1-associated myelopathy (HAM) / atypical HAM after allogeneic hematopoietic stem cell transplantation (allo-HSCT) and renal transplantation.
Kawano N; Yoshida S; Kawano S; Kuriyama T; Tahara Y; Toyofuku A; Manabe T; Doi A; Terasaka S; Yamashita K; Ueda Y; Ochiai H; Marutsuka K; Yamano Y; Shimoda K; Kikuchi I
J Clin Exp Hematop; 2018 Sep; 58(3):107-121. PubMed ID: 30089749
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic bone marrow transplantation from unrelated human T-cell leukemia virus-I-negative donors for adult T-cell leukemia/lymphoma: retrospective analysis of data from the Japan Marrow Donor Program.
Kato K; Kanda Y; Eto T; Muta T; Gondo H; Taniguchi S; Shibuya T; Utsunomiya A; Kawase T; Kato S; Morishima Y; Kodera Y; Harada M;
Biol Blood Marrow Transplant; 2007 Jan; 13(1):90-9. PubMed ID: 17222757
[TBL] [Abstract][Full Text] [Related]
5. Small number of HTLV-1-positive cells frequently remains during complete remission after allogeneic hematopoietic stem cell transplantation that are heterogeneous in origin among cases with adult T-cell leukemia/lymphoma.
Yamasaki R; Miyazaki Y; Moriuchi Y; Tsutsumi C; Fukushima T; Yoshida S; Taguchi J; Inoue Y; Matsuo E; Imaizumi Y; Imanishi D; Fujimoto T; Tsushima H; Honda S; Hata T; Tsukasaki K; Tomonaga M
Leukemia; 2007 Jun; 21(6):1212-7. PubMed ID: 17410191
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of adult T-Cell leukemia/lymphoma with allogeneic stem cell transplantation: single-institution experience.
Epstein-Peterson ZD; Ganesan N; Barker JN; Drullinsky PR; Ghione P; Jakubowski AA; Kumar A; Moskowitz AJ; Noy A; Perales MA; Ponce DM; Schoder H; Young JW; Giralt SA; Horwitz SM; Sauter CS; Dahi PB
Leuk Lymphoma; 2021 Sep; 62(9):2177-2183. PubMed ID: 33779474
[TBL] [Abstract][Full Text] [Related]
7. Stem cell transplantation for follicular lymphoma relapsed/refractory after prior rituximab: a comprehensive analysis from the NCCN lymphoma outcomes project.
Evens AM; Vanderplas A; LaCasce AS; Crosby AL; Nademanee AP; Kaminski MS; Abel GA; Millenson M; Czuczman MS; Rodriguez MA; Niland J; Zelenetz AD; Gordon LI; Friedberg JW
Cancer; 2013 Oct; 119(20):3662-71. PubMed ID: 23921646
[TBL] [Abstract][Full Text] [Related]
8. Stem cell therapy for HTLV-1 induced adult T-cell leukemia/lymphoma (ATLL): A comprehensive review.
Gholamzad A; Khakpour N; Gholamzad M; Roudaki Sarvandani MR; Khosroshahi EM; Asadi S; Rashidi M; Hashemi M
Pathol Res Pract; 2024 Mar; 255():155172. PubMed ID: 38340584
[TBL] [Abstract][Full Text] [Related]
9. Prevention of human T-cell lymphotropic virus type 1 infection and adult T-cell leukemia/lymphoma.
Yoshimitsu M; White Y; Arima N
Recent Results Cancer Res; 2014; 193():211-25. PubMed ID: 24008301
[TBL] [Abstract][Full Text] [Related]
10. Human T-lymphotropic virus 1 (HTLV-1)-associated lichenoid dermatitis induced by CD8+ T cells in HTLV-1 carrier, HTLV-1-associated myelopathy/tropical spastic paraparesis and adult T-cell leukemia/lymphoma.
Tokura Y; Ito T; Kawakami C; Sugita K; Kasuya A; Tatsuno K; Sawada Y; Nakamura M; Shimauchi T
J Dermatol; 2015 Oct; 42(10):967-74. PubMed ID: 26077665
[TBL] [Abstract][Full Text] [Related]
11. Pathogenicity and virulence of human T lymphotropic virus type-1 (HTLV-1) in oncogenesis: adult T-cell leukemia/lymphoma (ATLL).
Ahmadi Ghezeldasht S; Blackbourn DJ; Mosavat A; Rezaee SA
Crit Rev Clin Lab Sci; 2023 May; 60(3):189-211. PubMed ID: 36593730
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of Intermediate Risk Karyotype Acute Myeloid Leukemia in First Remission Undergoing Autologous Stem Cell Transplantation Compared With Allogeneic Stem Cell Transplantation and Chemotherapy Consolidation: A Retrospective, Propensity-score Adjusted Analysis.
Limvorapitak W; Barnett MJ; Hogge DE; Forrest DL; Nevill TJ; Narayanan S; Power MM; Nantel SH; Broady R; Song KW; Toze CL; Mourad YA; Sutherland HJ; Gerrie AS; White J; Sanford DS
Clin Lymphoma Myeloma Leuk; 2018 Nov; 18(11):e481-e491. PubMed ID: 30100330
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of young-onset adult T cell leukemia/lymphoma and preceding chronic refractory eczema and corneal injury by allogeneic hematopoietic stem cell transplantation.
Miyamura F; Kako S; Yamagami H; Sato K; Sato M; Terasako K; Kimura SI; Nakasone H; Aoki S; Okuda S; Yamazaki R; Oshima K; Yoshinaga K; Higuchi T; Nishida J; Demitsu T; Kakehashi A; Kanda Y
Int J Hematol; 2009 Oct; 90(3):397-401. PubMed ID: 19705056
[TBL] [Abstract][Full Text] [Related]
14. Outcome of Stem Cell Transplantation in HTLV-1-Associated North American Adult T-Cell Leukemia/Lymphoma.
Bazarbachi AH; Reef D; Narvel H; Patel R; Al Hamed R; Vikash S; Neupane K; Atalla E; Thakkar A; Rahman S; Shah U; Adrianzen-Herrera D; Quinn R; Zareef S; Rabinovich E; De Castro A; Joseph F; Gillick K; Mustafa J; Khatun F; Lombardo A; Townsend-Nugent L; Abreu M; Chambers N; Elkind R; Shi Y; Wang Y; Derman O; Gritsman K; Steidl U; Goldfinger M; Kornblum N; Shastri A; Mantzaris I; Bachier-Rodriguez L; Shah N; Cooper D; Verma A; Ye BH; Janakiram M; Sica RA
Clin Hematol Int; 2023 Jun; 5(2-3):78-91. PubMed ID: 36918485
[TBL] [Abstract][Full Text] [Related]
15. Autologous and allogeneic stem-cell transplantation for transformed follicular lymphoma: a report of the Canadian blood and marrow transplant group.
Villa D; Crump M; Panzarella T; Savage KJ; Toze CL; Stewart DA; MacDonald DA; Buckstein R; Lee C; Alzahrani M; Rubinger M; Foley R; Xenocostas A; Sabloff M; Muccilli A; Chua N; Couture F; Larouche JF; Cohen S; Connors JM; Ambler K; Al-Tourah A; Ramadan KM; Kuruvilla J
J Clin Oncol; 2013 Mar; 31(9):1164-71. PubMed ID: 23401459
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma with HTLV-1-associated myelopathy.
Sakamoto H; Itonaga H; Sawayama Y; Kojima A; Chiwata M; Fujioka M; Kitanosono H; Horai M; Miyazaki T; Shiraishi H; Imaizumi Y; Yoshida S; Hata T; Yamano Y; Miyazaki Y
Int J Hematol; 2021 May; 113(5):765-769. PubMed ID: 33423163
[TBL] [Abstract][Full Text] [Related]
17. Phase II Trial of Tandem High-Dose Chemotherapy with Autologous Stem Cell Transplantation Followed by Reduced-Intensity Allogeneic Stem Cell Transplantation for Patients with High-Risk Lymphoma.
Chen YB; Li S; Fisher DC; Driscoll J; Del Rio C; Abramson J; Armand P; Barnes J; Brown J; Cutler C; El-Jawahri A; Ho VT; Hochberg E; McAfee S; Takvorian R; Spitzer TR; Antin JH; Soiffer R; Jacobsen E
Biol Blood Marrow Transplant; 2015 Sep; 21(9):1583-8. PubMed ID: 26009261
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic stem cell transplantation for adult T-cell leukemia/lymphoma.
Okamura J; Uike N; Utsunomiya A; Tanosaki R
Int J Hematol; 2007 Aug; 86(2):118-25. PubMed ID: 17875524
[TBL] [Abstract][Full Text] [Related]
19. HTLV-1 bZIP factor-specific CD4 T cell responses in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation.
Narita T; Ishida T; Masaki A; Suzuki S; Ito A; Mori F; Yamada T; Ri M; Kusumoto S; Komatsu H; Miyazaki Y; Takatsuka Y; Utsunomiya A; Niimi A; Iida S; Ueda R
J Immunol; 2014 Feb; 192(3):940-7. PubMed ID: 24363428
[TBL] [Abstract][Full Text] [Related]
20. Graft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation.
Harashima N; Kurihara K; Utsunomiya A; Tanosaki R; Hanabuchi S; Masuda M; Ohashi T; Fukui F; Hasegawa A; Masuda T; Takaue Y; Okamura J; Kannagi M
Cancer Res; 2004 Jan; 64(1):391-9. PubMed ID: 14729650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
